Given the following molecule represented by the SMILES string: CCc1oc2ccccc2c1C(=O)c1cc(Br)c([O-])c(Br)c1, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The molecule is a complex organic compound with multiple functional groups including a benzene ring, an amide group, a bromine atom, and a negatively charged oxygen. This structure suggests it could be a ligand or inhibitor for proteins that interact with aromatic compounds or have binding sites for amides.
Step 2: The presence of the amide group (C(=O)N) is particularly noteworthy as it could potentially bind to protein targets that have amine-binding pockets, such as certain G-protein coupled receptors (GPCRs). GPCRs are known to be involved in various physiological processes and are often targeted by drugs.
Step 3: The bromine atom (-Br) is a polarizable substituent which might increase the moleculeâ€™s affinity for proteins with hydrophobic binding pockets, such as some cytochrome P450 enzymes (e.g., CYP2C9, CYP2C19, CYP2D6, CYP3A4), which are involved in drug metabolism.
Step 4: Given the molecule's potential to act as a ligand or inhibitor, it could influence the function of several neurotransmitter receptors, such as HTR2A, HTR2B, HTR2C, and HTR6, which are GPCRs involved in serotonin signaling, and DRD2, DRD3, and DRD4, which are dopamine receptors.
Step 5: The molecule also has a potential to interact with other receptors like CHRM1, CHRM3, and CHRM4, which are muscarinic acetylcholine receptors, and may affect their activity.
Summary of related gene names:
- CYP2C9
- CYP2C19
- CYP2D6
- CYP3A4
- HTR2A
- HTR2B
- HTR2C
- HTR6
- DRD2
- DRD3
- DRD4
- CHRM1
- CHRM3
- CHRM4 Step 5: The molecule's structure and functional groups suggest it may interact with several genes involved in neurotransmission, drug metabolism, and receptor binding. These include CYP enzymes, serotonin receptors (HTR family), dopamine receptors (DRD family), and muscarinic acetylcholine receptors (CHRM family). The specific interactions would depend on the precise binding sites and affinities of the molecule for these proteins.
